IL-17A Expression is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Sep 3

PMID 21887369

Citations 28

Authors

Ellen M Moran

Rene Heydrich

Chin Teck Ng

Tajvur P Saber

Jennifer McCormick

Joachim Sieper

Heiner Appel

Ursula Fearon

Douglas J Veale

Affiliations

Soon will be listed here.

Abstract

Introduction: This study examines the expression of IL-17A-secreting cells within the inflamed synovium and the relationship to in vivo joint hypoxia measurements.

Methods: IL-17A expression was quantified in synovial tissue (ST), serum and synovial fluid (SF) by immunohistochemistry and MSD-plex assays. IL-6 SF and serum levels were measured by MSD-plex assays. Dual immunofluorescence for IL-17A was quantified in ST CD15+ cells (neutrophils), Tryptase+ (mast cells) and CD4+ (T cells). Synovial tissue oxygen (tpO(2)) levels were measured under direct visualisation at arthroscopy. Synovial infiltration was assessed using immunohistochemistry for cell specific markers. Peripheral blood mononuclear and polymorphonuclear cells were isolated and exposed to normoxic or 3% hypoxic conditions. IL-17A and IL-6 were quantified as above in culture supernatants.

Results: IL-17A expression was localised to mononuclear and polymorphonuclear (PMN) cells in inflamed ST. Dual immunoflourescent staining co-localised IL-17A expression with CD15+ neutrophils Tryptase+ mast cells and CD4+T cells. % IL-17A positivity was highest on CD15+ neutrophils, followed by mast cells and then CD4+T-cells. The number of IL-17A-secreting PMN cells significantly correlated with sublining CD68 expression (r = 0.618, p<0.01). IL-17A SF levels correlated with IL-6 SF levels (r = 0.675, p<0.01). Patients categorized according to tp0(2)< or >20 mmHg, showed those with low tp0(2)<20 mmHg had significantly higher IL-17A+ mononuclear cells with no difference observed for PMNs. Exposure of mononuclear and polymorphonuclear cells to 3% hypoxia, significantly induced IL-6 in mononuclear cells, but had no effect on IL-17A expression in mononuclear and polymorphonuclear cells.

Conclusion: This study demonstrates IL-17A expression is localised to several immune cell subtypes within the inflamed synovial tissue, further supporting the concept that IL-17A is a key mediator in inflammatory arthritis. The association of hypoxia with Il-17A expression appears to be indirect, probably through hypoxia-induced pro-inflammatory pathways and leukocyte influx within the joint microenvironment.

Citing Articles

Interleukin-17: A Putative Novel Pharmacological Target for Pathological Pain.

Gao S, Liu L, Li D, Liu D, Zhang L, Wu J Curr Neuropharmacol. 2023; 22(2):204-216.

PMID: 37581321 PMC: 10788884. DOI: 10.2174/1570159X21666230811142713.

Novel immune cell phenotypes in spondyloarthritis pathogenesis.

Mauro D, Simone D, Bucci L, Ciccia F Semin Immunopathol. 2021; 43(2):265-277.

PMID: 33569634 PMC: 7990868. DOI: 10.1007/s00281-021-00837-0.

Studying Neutrophil Function in vitro: Cell Models and Environmental Factors.

Blanter M, Gouwy M, Struyf S J Inflamm Res. 2021; 14:141-162.

PMID: 33505167 PMC: 7829132. DOI: 10.2147/JIR.S284941.

Endogenous stimulation is responsible for the high frequency of IL-17A-producing neutrophils in patients with rheumatoid arthritis.

Gonzalez-Orozco M, Barbosa-Cobos R, Santana-Sanchez P, Becerril-Mendoza L, Limon-Camacho L, Juarez-Estrada A Allergy Asthma Clin Immunol. 2019; 15:44.

PMID: 31388340 PMC: 6676628. DOI: 10.1186/s13223-019-0359-9.

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies.

McGonagle D, McInnes I, Kirkham B, Sherlock J, Moots R Ann Rheum Dis. 2019; 78(9):1167-1178.

PMID: 31278139 PMC: 6788885. DOI: 10.1136/annrheumdis-2019-215356.

References

Sandler C, Lindstedt K, Joutsiniemi S, Lappalainen J, Juutilainen T, Kolah J . Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra. Inflamm Res. 2007; 56(6):230-9. DOI: 10.1007/s00011-007-6135-1. View

Gabriel S, Michaud K . Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009; 11(3):229. PMC: 2714099. DOI: 10.1186/ar2669. View

Hollander A, Corke K, Freemont A, Lewis C . Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 2001; 44(7):1540-4. DOI: 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7. View

Makino Y, Nakamura H, Ikeda E, Ohnuma K, Yamauchi K, Yabe Y . Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol. 2003; 171(12):6534-40. DOI: 10.4049/jimmunol.171.12.6534. View

Shin K, Nigrovic P, Crish J, Boilard E, McNeil H, Larabee K . Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol. 2008; 182(1):647-56. PMC: 2610352. DOI: 10.4049/jimmunol.182.1.647. View

Biniecka M, Kennedy A, Fearon U, Ng C, Veale D, OSullivan J . Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis. 2009; 69(6):1172-8. DOI: 10.1136/ard.2009.111211. View

Page G, Sattler A, Kersten S, Thiel A, Radbruch A, Miossec P . Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression. Am J Pathol. 2004; 164(2):409-17. PMC: 1602247. DOI: 10.1016/S0002-9440(10)63131-8. View

Wang D, Zhao Y, Wang G, Sun B, Kong Q, Zhao K . IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression. J Neuroimmunol. 2009; 212(1-2):17-25. DOI: 10.1016/j.jneuroim.2009.04.007. View

Miossec P, Korn T, Kuchroo V . Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361(9):888-98. DOI: 10.1056/NEJMra0707449. View

10.

Moran E, Mullan R, McCormick J, Connolly M, Sullivan O, FitzGerald O . Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther. 2009; 11(4):R113. PMC: 2745795. DOI: 10.1186/ar2772. View

11.

Yue C, You X, Zhao L, Wang H, Tang F, Zhang F . The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients. Rheumatol Int. 2009; 30(12):1553-7. DOI: 10.1007/s00296-009-1179-x. View

12.

Kennedy A, Ng C, Chang T, Biniecka M, OSullivan J, Heffernan E . Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia. Arthritis Rheum. 2011; 63(4):923-32. DOI: 10.1002/art.30221. View

13.

Veale D, Rogers S, FitzGerald O . Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol. 1994; 33(2):133-8. DOI: 10.1093/rheumatology/33.2.133. View

14.

Jin Y, Silverman A, Vannucci S . Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke. 2009; 40(9):3107-12. DOI: 10.1161/STROKEAHA.109.549691. View

15.

Hueber A, Asquith D, Miller A, Reilly J, Kerr S, Leipe J . Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol. 2010; 184(7):3336-40. DOI: 10.4049/jimmunol.0903566. View

16.

Iwamoto T, Okamoto H, Toyama Y, Momohara S . Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 2008; 275(18):4448-55. DOI: 10.1111/j.1742-4658.2008.06580.x. View

17.

Yin Y, Wen S, Li G, Wang D . Hypoxia enhances stimulating effect of amyloid beta peptide (25-35) for interleukin 17 and T helper lymphocyte subtype 17 upregulation in cultured peripheral blood mononuclear cells. Microbiol Immunol. 2009; 53(5):281-6. DOI: 10.1111/j.1348-0421.2009.00120.x. View

18.

Brennan F, Foey A . Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions. Arthritis Res. 2002; 4 Suppl 3:S177-82. PMC: 3240132. DOI: 10.1186/ar556. View

19.

Fantone J, Ward P . Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease. Hum Pathol. 1985; 16(10):973-8. DOI: 10.1016/s0046-8177(85)80273-2. View

20.

Shahrara S, Pickens S, Mandelin 2nd A, Karpus W, Huang Q, Kolls J . IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol. 2010; 184(8):4479-87. PMC: 2858914. DOI: 10.4049/jimmunol.0901942. View